Search results
Nektar Therapeutics Q1 Earnings Call Highlights
Nektar Therapeutics (NASDAQ:NKTR) outlined plans to advance its lead regulatory T-cell (Treg) therapy rezpegaldesleukin (REZPEG) into
Lexicon Pharmaceuticals Q1 Earnings Call Highlights
Lexicon Pharmaceuticals (NASDAQ:LXRX) executives highlighted progress across late-stage regulatory programs and efforts to bolster the company’s financial position during the company’s
International: Update on Global Regions
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the
Take-Two Interactive (TTWO) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Take-Two Interactive (TTWO) closed at $220.19, marking a -1.48% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.84%
Chewy (CHWY) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Chewy (CHWY) closed at $22.97, marking a -2.96% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.84%. Meanwhile, the Dow
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
In the latest close session, Humacyte, Inc. (HUMA) was down 1.85% at $1.06. The stock trailed the S&P 500, which registered a daily gain of 0.84%. Meanwhile, the Dow experienced a rise of 0.03%, and
Intrusion Inc. (INTZ) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Intrusion Inc. (INTZ) closed at $0.77, marking a -3.75% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.84%. Elsewhere
B. Riley Financial Q1 Earnings Call Highlights
B. Riley Financial (NASDAQ:RILY) reported a sharp first-quarter profit and lower debt, with executives saying the firm has regained
California Resources Q1 Earnings Call Highlights
California Resources (NYSE:CRC) reported a stronger-than-expected first quarter and raised its 2026 outlook, citing higher oil
American Express Shareholders Back Board, Reject Proposals as 2025 Results Hit Records
American Express (NYSE:AXP) shareholders elected all 13 director nominees, ratified PricewaterhouseCoopers as the company’s independent registered